ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma

ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma

BackgroundThe four ERBB tyrosine kinase family members [ERBB1 (epidermal growth factor receptor, EGFR), ERBB2 (HER2), ERBB3 (HER3), and ERBB4 (HER4)] (ERBB receptor family) have been shown, according to previous studies, to be related to the cutaneous melanoma. ERBB3 is the only member of the ERBBs...

Full description

Bibliographic Details
Main Authors:	Shougang Liu, Rong Geng, Eryi Lin, Peizhen Zhao, Yongfeng Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Genetics
Subjects:	ERBB family immunochemistry immune infiltrates prognostic cutaneous melanoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2021.602160/full

Similar Items

FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma
by: Zhenguo Cai, et al.
Published: (2023-11-01)

TICRR Overexpression Enhances Disease Aggressiveness and Immune Infiltration of Cutaneous Melanoma
by: Chen C, et al.
Published: (2024-09-01)

Significance of immunogenic cell death-related genes in prognosis prediction and immune microenvironment landscape of patients with cutaneous melanoma
by: Weijiang Fu, et al.
Published: (2022-09-01)

Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients
by: Biao Huang, et al.
Published: (2020-05-01)

Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study
by: Yong Qin, et al.
Published: (2017-06-01)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
by: Kai Kang, et al.
Published: (2020-09-01)

High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma
by: Shixin Zhao, et al.
Published: (2022-05-01)

ERBB2 promoter demethylation and immune cell infiltration promote a poor prognosis for cancer patients
by: Hongting Wang, et al.
Published: (2022-09-01)

DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma
by: Liping Liang, et al.
Published: (2022-07-01)

Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma
by: Jun Tian, et al.
Published: (2021-08-01)

ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
by: TengFei Deng, et al.
Published: (2023-06-01)

System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma
by: Shixin Zhao, et al.
Published: (2023-11-01)

Dabrafenib for cutaneous melanoma infiltrating the vitreous: regression of metastasis and occurrence of uveitis as a secondary effect
by: Alex Fonollosa, et al.
Published: (2017-07-01)

Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastasesResearch in context
by: Eftychia Chatziioannou, et al.
Published: (2023-07-01)

A Novel Risk Model Based on Autophagy-Related LncRNAs Predicts Prognosis and Indicates Immune Infiltration Landscape of Patients With Cutaneous Melanoma
by: Qi Shu, et al.
Published: (2022-04-01)

Commentary: A novel signature of 23 immunity related gene pairs is prognostic of cutaneous melanoma
by: Ruihuan Shen, et al.
Published: (2023-06-01)

Role of hippo pathway and cuproptosis-related genes in immune infiltration and prognosis of skin cutaneous melanoma
by: Haozhen Lv, et al.
Published: (2024-03-01)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
by: Nian Liu, et al.
Published: (2020-08-01)

Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients
by: Hu Z, et al.
Published: (2020-12-01)

The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma
by: Yuming Sun, et al.
Published: (2023-04-01)

Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
by: Fabienne Maibach, et al.
Published: (2020-09-01)

Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma
by: Hanwen Wang, et al.
Published: (2021-12-01)

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
by: Junya Yan, et al.
Published: (2020-11-01)

Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
by: Yoshiyuki Nakamura, et al.
Published: (2020-12-01)

A novel risk model based on anoikis: Predicting prognosis and immune infiltration in cutaneous melanoma
by: Yi Zhou, et al.
Published: (2023-01-01)

A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies
by: Yujian Xu, et al.
Published: (2022-04-01)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
by: Yujian Xu, et al.
Published: (2022-07-01)

Identification and validation of a TTN-associated immune prognostic model for skin cutaneous melanoma
by: Qirui Wang, et al.
Published: (2023-01-01)

Prognostic biomarker CCR6 and its correlation with immune infiltration in cutaneous melanoma
by: Yeltai Nurzat, et al.
Published: (2023-04-01)

Construction and validation of a novel prognostic signature for cutaneous melanoma based on ferroptosis-related genes
by: Wenna Guo, et al.
Published: (2023-05-01)

Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition
by: Evan DuBose, et al.
Published: (2024-05-01)

The impact of MITF expression on tumor-infiltrating lymphocytes in melanoma: Insights into immune microenvironment dynamics
by: Damir Vučinić, et al.
Published: (2025-02-01)

Cardiac Melanoma Metastasis with ERBB2 Gene Amplification: A Potential for Future Targeted Therapy
by: Polona Gams, et al.
Published: (2021-03-01)

Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy
by: Chiao-En Wu, et al.
Published: (2015-05-01)

Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
by: Jiahua Xing, et al.
Published: (2022-07-01)

Identification of Potential Prognostic Biomarkers Associated With Cancerometastasis in Skin Cutaneous Melanoma
by: Yang Li, et al.
Published: (2021-07-01)

Cuproptosis-related DNA methylation signature predict prognosis and immune microenvironment in cutaneous melanoma
by: Liucun Zhu, et al.
Published: (2024-06-01)

A Ferroptosis-Related Gene Model Predicts Prognosis and Immune Microenvironment for Cutaneous Melanoma
by: Congcong Xu, et al.
Published: (2021-08-01)

Immune-related risk score: An immune-cell-pair-based prognostic model for cutaneous melanoma
by: Mingjia Li, et al.
Published: (2023-02-01)

Multivariable prognostic analyses of Chinese acral and cutaneous melanoma after surgical treatment for the past five years in a single cancer center
by: LIN Xinyi, SUN Wei, HU Tu, WANG Chunmeng, YAN Wangjun, LUO Zhiguo, LIU Xin, ZHONG Jingqin, ZOU Zijian, XU Yu, CHEN Yong
Published: (2022-12-01)